1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. Century Therapeutics Acquires Clade Therapeutics

M&A Deal Summary

Century Therapeutics Acquires Clade Therapeutics

On April 11, 2024, Century Therapeutics acquired life science company Clade Therapeutics

Acquisition Highlights
  • This is Century Therapeutics’ 2nd transaction in the Life Science sector.
  • This is Century Therapeutics’ 1st transaction in the United States.
  • This is Century Therapeutics’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2024-04-11
Target Clade Therapeutics
Sector Life Science
Buyer(s) Century Therapeutics
Deal Type Add-on Acquisition
Advisor(s) Cooley (Legal)

Target

Clade Therapeutics

Boston, Massachusetts, United States
Clade Therapeutics is a biopharmaceutical company focused on discovering and delivering engineerable, off-the-shelf, scalable, and consistent stem cell-based medicines. The company provides a robust cellular platform with stem-cell-derived immune cells for the treatment of cancer and autoimmune diseases. Clade Therapeutics is based in Boston, Massachusetts.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Century Therapeutics

Philadelphia, Pennsylvania, United States
Category Company
Founded 2019
Sector Life Science
DESCRIPTION

Century Therapeutics LLC is a developer of curative cell therapy products for cancer that overcome the limitations of first-generation cell therapies. Century Therapeutics was founded in 2019 and is based in Philadelphia, Pennsylvania.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-23 Empirica Therapeutics

Hamilton, Ontario, Canada

Empirica Therapeutics is a developer of iPSC-derived allogeneic cell therapies against glioblastoma (GBM). Empirica Therapeutics is based in Hamilton, Ontario.

Buy -
Mergr

Solution for

Product

Company

Legal